[HTML][HTML] Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review

M Albratty, HA Alhazmi - Arabian Journal of Chemistry, 2022 - Elsevier
Pyridines and pyrimidines are the class of heterocyclic nitrogenous compounds having
plethora of applications in anticancer drug development. These synthetic sources serve as …

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs

Z Gagic, D Ruzic, N Djokovic, T Djikic… - Frontiers in …, 2020 - frontiersin.org
Rational drug design implies usage of molecular modeling techniques such as
pharmacophore modeling, molecular dynamics, virtual screening, and molecular docking to …

Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers

MM Alanazi, IH Eissa, NA Alsaif… - Journal of Enzyme …, 2021 - Taylor & Francis
Vascular endothelial growth factor receptor-2 (VEGFR-2) plays a critical role in cancer
angiogenesis. Inhibition of VEGFR-2 activity proved effective suppression of tumour …

Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies

RG Yousef, A Elwan, IMM Gobaara… - Journal of Enzyme …, 2022 - Taylor & Francis
Abstract New nicotinamide derivatives 6, 7, 10, and 11 were designed and synthesised
based on the essential features of the VEGFR-2 inhibitors. Compound 10 revealed the …

Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers

NA Alsaif, MS Taghour, MM Alanazi… - Journal of enzyme …, 2021 - Taylor & Francis
Herein, a new wave of bis ([1, 2, 4] triazolo)[4, 3-a: 3', 4'-c] quinoxaline derivatives have been
successfully designed and synthesised. The synthesised derivatives were biologically …

New proapoptotic chemotherapeutic agents based on the quinolone-3-carboxamide scaffold acting by VEGFR-2 inhibition

ZS El-Fakharany, YM Nissan, NK Sedky, RK Arafa… - Scientific Reports, 2023 - nature.com
In the current study, we designed and synthesized a series of new quinoline derivatives 10a-
p as antiproliferative agents targeting cancer through inhibition of VEGFR-2. Preliminary …

[HTML][HTML] AcrAB− TolC, a major efflux pump in Gram negative bacteria: toward understanding its operation mechanism

S Jang - BMB reports, 2023 - ncbi.nlm.nih.gov
Antibiotic resistance (AR) is a silent pandemic that kills millions worldwide. Although the
development of new therapeutic agents against antibiotic resistance is in urgent demand …

The use of machine learning modeling, virtual screening, molecular docking, and molecular dynamics simulations to identify potential VEGFR2 kinase inhibitors

A Salimi, JH Lim, JH Jang, JY Lee - Scientific Reports, 2022 - nature.com
Targeting the signaling pathway of the Vascular endothelial growth factor receptor-2 is a
promising approach that has drawn attention in the quest to develop novel anti-cancer drugs …

Discovery of potent thieno [2, 3-d] pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations

EZ Elrazaz, RAT Serya, NSM Ismail, A Albohy… - Bioorganic …, 2021 - Elsevier
Vascular endothelial growth factor receptor (VEGFR) is one of the well-known targets that
control angiogenesis and cancer progression. In this study, we are reporting the design …

Applications of quantitative structure-activity relationships (QSAR) based virtual screening in drug design: A review

PGR Achary - Mini Reviews in Medicinal Chemistry, 2020 - ingentaconnect.com
The scientists, and the researchers around the globe generate tremendous amount of
information everyday; for instance, so far more than 74 million molecules are registered in …